AMG 319

Generic Name: AMG 319
Study IDStudied Indication or DiseasePhaseStudy TitleSynopsis
20101262Relapsed or Refractory Lymphoid Malignancies1A Phase 1, First-in-Human Study Evaluating the Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of AMG 319 in Adult Subjects with Relapsed or Refractory Lymphoid Malignancies AMG 319